NeuroSense and PhaseV are collaborating to use causal machine learning for clinical trial analysis and optimization of NeuroSense’s ALS therapy. The therapy, PrimeC, is…
NeuroSense and PhaseV are collaborating to use causal machine learning for clinical trial analysis and optimization of NeuroSense’s ALS therapy. The therapy, PrimeC, is…
Daniela Rus, MIT CSAIL Director, has developed a new idea called Liquid Neural Networks which could help to solve some of AI’s complexity problems…
Login below or Register Now.
Already registered? Login.